Pulmonary extranodal NK/T-cell lymphoma: A clinicopathological analysis of five patients.

IF 3.1 4区 医学 Q2 PATHOLOGY
Cytojournal Pub Date : 2025-02-11 eCollection Date: 2025-01-01 DOI:10.25259/Cytojournal_177_2024
Qing Li, Yunxiao Zhang, Hui Sun, Xue Wang, Di Wu
{"title":"Pulmonary extranodal NK/T-cell lymphoma: A clinicopathological analysis of five patients.","authors":"Qing Li, Yunxiao Zhang, Hui Sun, Xue Wang, Di Wu","doi":"10.25259/Cytojournal_177_2024","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Our goal was to investigate the clinicopathological features of extranodal natural killer (NK)/T-cell lymphoma (ENKTL).</p><p><strong>Material and methods: </strong>A total of five newly identified (5 biopsy samples) untreated cases of pulmonary ENKTL were collected between January 2016 and January 2024. The clinical characteristic pathology features on hematoxylin-eosin-staining sections, immunohistochemistry stating, treatment responses, and prognoses were retrospectively analyzed.</p><p><strong>Results: </strong>Among the five patients, four were male and one was female, and their ages varied between 48 and 63 years. All five patients were initially diagnosed with stage IV disease. Histological examination revealed either scattered or localized clusters of highly pleomorphic tumor lymphocytes associated with necrosis and a significant presence of inflammatory cells. Most tumor cells expressed cluster of differentiation (CD)3, T-cell intracellular antigen-1, and granzyme B, whereas there was an absence of CD20, CD79a, or CD5 expression. The expression of CD56 was detected in four out of the five patients. Only two patients were tested for programmed cell death ligand 1, with one out of two patients exhibiting positivity (Tumor Proportion Score (TPS) 80%). The Ki-67 proliferation index varied from 40% to 90%. All patients tested positive for Epstein- Barr virus-encoded ribonucleic acid (RNA) (EBER) through fluorescence <i>in situ</i> hybridization (FISH). Five of the patients died during follow-up. Four of these patients underwent standard chemotherapy, with survival durations ranging from 3 to 24 months. One patient received only supportive treatment, resulting in a survival time of 1 month.</p><p><strong>Conclusion: </strong>Pulmonary ENKTL is an uncommon, aggressive cancer associated with a bleak prognosis. The likelihood of misdiagnosis is high because of the presence of necrotic lesions and various cell types. Accurate diagnosis relies heavily on immunohistochemistry and EBER FISH. The aim of our study was to facilitate improved diagnosis of pulmonary ENKTL and to identify treatment strategies for affected individuals.</p>","PeriodicalId":49082,"journal":{"name":"Cytojournal","volume":"22 ","pages":"14"},"PeriodicalIF":3.1000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11932977/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cytojournal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25259/Cytojournal_177_2024","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Our goal was to investigate the clinicopathological features of extranodal natural killer (NK)/T-cell lymphoma (ENKTL).

Material and methods: A total of five newly identified (5 biopsy samples) untreated cases of pulmonary ENKTL were collected between January 2016 and January 2024. The clinical characteristic pathology features on hematoxylin-eosin-staining sections, immunohistochemistry stating, treatment responses, and prognoses were retrospectively analyzed.

Results: Among the five patients, four were male and one was female, and their ages varied between 48 and 63 years. All five patients were initially diagnosed with stage IV disease. Histological examination revealed either scattered or localized clusters of highly pleomorphic tumor lymphocytes associated with necrosis and a significant presence of inflammatory cells. Most tumor cells expressed cluster of differentiation (CD)3, T-cell intracellular antigen-1, and granzyme B, whereas there was an absence of CD20, CD79a, or CD5 expression. The expression of CD56 was detected in four out of the five patients. Only two patients were tested for programmed cell death ligand 1, with one out of two patients exhibiting positivity (Tumor Proportion Score (TPS) 80%). The Ki-67 proliferation index varied from 40% to 90%. All patients tested positive for Epstein- Barr virus-encoded ribonucleic acid (RNA) (EBER) through fluorescence in situ hybridization (FISH). Five of the patients died during follow-up. Four of these patients underwent standard chemotherapy, with survival durations ranging from 3 to 24 months. One patient received only supportive treatment, resulting in a survival time of 1 month.

Conclusion: Pulmonary ENKTL is an uncommon, aggressive cancer associated with a bleak prognosis. The likelihood of misdiagnosis is high because of the presence of necrotic lesions and various cell types. Accurate diagnosis relies heavily on immunohistochemistry and EBER FISH. The aim of our study was to facilitate improved diagnosis of pulmonary ENKTL and to identify treatment strategies for affected individuals.

Abstract Image

肺结外NK/ t细胞淋巴瘤:5例临床病理分析。
目的:探讨结外自然杀伤(NK)/ t细胞淋巴瘤(ENKTL)的临床病理特征。材料和方法:2016年1月至2024年1月,共收集5例新确诊(5例活检样本)未经治疗的肺ENKTL病例。回顾性分析苏木精-伊红染色切片的临床病理特征、免疫组化状态、治疗反应及预后。结果:5例患者中男性4例,女性1例,年龄在48 ~ 63岁之间。所有五名患者最初都被诊断为IV期疾病。组织学检查显示分散或局部的高度多形性肿瘤淋巴细胞簇,并伴有坏死和明显的炎症细胞。大多数肿瘤细胞表达分化簇(cd3)、t细胞胞内抗原-1和颗粒酶B,而CD20、CD79a和CD5不表达。5例患者中有4例检测到CD56的表达。只有两名患者检测了程序性细胞死亡配体1,两名患者中有一名呈阳性(肿瘤比例评分(TPS) 80%)。Ki-67增殖指数为40% ~ 90%。所有患者通过荧光原位杂交(FISH)检测Epstein- Barr病毒编码核糖核酸(RNA) (EBER)阳性。5例患者在随访期间死亡。其中4例患者接受了标准化疗,生存时间从3到24个月不等。1例患者仅接受支持性治疗,存活时间为1个月。结论:肺ENKTL是一种罕见的侵袭性肿瘤,预后较差。由于存在坏死性病变和各种细胞类型,误诊的可能性很高。准确的诊断很大程度上依赖于免疫组织化学和EBER FISH。我们研究的目的是促进改善肺部ENKTL的诊断,并确定受影响个体的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cytojournal
Cytojournal PATHOLOGY-
CiteScore
2.20
自引率
42.10%
发文量
56
审稿时长
>12 weeks
期刊介绍: The CytoJournal is an open-access peer-reviewed journal committed to publishing high-quality articles in the field of Diagnostic Cytopathology including Molecular aspects. The journal is owned by the Cytopathology Foundation and published by the Scientific Scholar.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信